As rates of advanced prostate cancer rise, the American Cancer Society is recommending that most men age 50 to 69 get a PSA ...
Oral psoriatic arthritis treatment reached a milestone as icotrokinra (ICOTYDE) cleared its Phase 3 primary joint endpoint at ...
Demographic factors and baseline characteristics have the greatest association with treatment persistence and response among ...
TYK2 inhibitor deucravacitinib was approved by the FDA in 2022 for patients with moderate to severe plaque psoriasis. In ...
Concerns about overdiagnosis and overtreatment had driven a shift away from routine screening. But advances in clinical ...
The American Cancer Society now recommends most men ages 50 to 69 get a PSA blood test every other year, and Black men and ...
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...
How Today's Decision to Drive Buzzed Can Disrupt Tomorrow's Plans NEW YORK, Nov. 10, 2026 /PRNewswire/ -- The Ad Council and ...
Cancer isn't the leading cause of death in the United States; heart disease ranks first in that regard. But it's cancer that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results